According to this report, pharmaceutical spending reached around USD 800 billion across OECD countries in 2013, which is about 20% of total health spending on average.

It also believes that health care is improving too slowly to meet the rising strains of chronic diseases. Through the most recent comparable data on the performance of health systems in OECD countries and a new set of dashboards, Health at a Glance 2015 shows that all countries have wide scope for improving the quality of health care and tackling unhealthy lifestyles. This edition includes a special focus on the pharmaceutical sector, chapters on health care resources, health expenditure and outcomes as well as new indicators on health workforce migration.

To read the full report on the website